Scholars Central

Short communicationPublished 11 Sep 2020

Invariant natural killer T cell activation by α-GalCer analogues and novel anti-epidermal growth factor receptor -antibody glycol-conjugates for onco-immunotherapy

Authors: Didier Dubreuil

Insights in Immunology

Volume 3 · Issue 3 · Pages 1–1

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Invariant NKT (iNKT) lymphocytes recognize lipids presented by CD1d and respond by a rapid release of cytokines that regulate innate and adaptive immune responses. They also show potent cytotoxic activity against cancer. α-GalactosylCeramide (α-GalCer) is the canonical iNKT agonist. With the aim to mediate a local immune response close to EGFR-tumour environment α-GalCer derivatives have been associated to the anti-EGFR monoclonal antibody. Biological activities of α-GalCer analogues and MoAb-conjugates were assessed to highlight dual cytotoxic performances. In comparison with the canonical α-GalCer (KRN7000), novel α-GalCer analogues proved to be more potent by several orders of magnitude using APC that express CD1d for interferon secretion were discovered. Intriguingly, unlike α-GalCer, they also proved to be active when loaded on several human cancer cell lines known as not expressing CD1d. This latter result reveals a paramount effect of modified α-GalCer on CD1d/TCR complex stabilization that occurs on cancer cell bed without recruitment of usual APCs. Thus, association of α-GalCer analogues to anti-EGFR monoclonal antibody is also able to restore iNKT stimulation and to increase antibody cytotoxicity.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Insights in Immunology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInsights in Immunology
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Didier Dubreuil”